Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. Baby’s first breath: How one landmark program in China has saved 150,000 newborns
Helping Babies Breath Hi Res

Baby’s first breath: How one landmark program in China has saved 150,000 newborns

Sixty seconds. That’s how much time a healthcare professional has to ensure that a newborn takes a first breath in order for that baby to have a healthy start in life.

But far too often newborns aren’t able to take that first breath on their own.

It’s a condition known as birth asphyxia—and it’s one of the world’s leading causes of infant mortality. In fact, some 10 million newborns worldwide have difficulty breathing at birth each year. And in China, over 73,000 babies died from the complication in 2004 alone.

So to help change that alarming statistic, Johnson & Johnson formed a first-of-its-kind public-private partnership with the Chinese government and other professional associations to launch the “Freedom of Breath, Fountain of Life” training program.

The goal: help prevent birth asphyxia in Chinese hospitals by ensuring that every delivery had at least one person trained in neonatal resuscitation present.

Today, as the program marks its 10-year anniversary, the initiative has saved an estimated 150,000 newborns across the country.

And that’s just one heartwarming stat.

As you’ll see in this infographic, there are more inspiring facts, figures and stories behind the formation of this landmark partnership—and the many children to whom it’s given a healthy start.

Cina NRP Final Infographic

null

More from Johnson & Johnson

What is head and neck cancer?

This complex type of cancer can cause malignancies of the mouth, throat, larynx and nasal cavity. Find out how Johnson & Johnson is innovating to change the current treatment paradigm.

5 things we now know about atrial fibrillation

More than 50 million people worldwide are affected by this common type of heart arrhythmia. Learn the facts behind this heart condition, plus one patient’s diagnosis story.

Shockwave: Inside the development of a cutting-edge system to treat coronary artery disease

Johnson & Johnson’s Patrick Stephens explains how innovative technology using ultrasonic acoustic pressure waves has made the treatment of certain types of cardiovascular disease easier for doctors and safer for patients.